Host: |
Goat |
Applications: |
Pep-ELISA/IHC |
Reactivity: |
Human/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Goat polyclonal antibody anti-NET1/ARHGEF8 (C-Term) is suitable for use in ELISA and Immunohistochemistry research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA |
Purification: |
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
Concentration: |
0.5 mg/mL |
Dilution Range: |
IHC-Recommended concentration, 1-2µg/mlELISA-antibody detection limit dilution 1:128000. |
Storage Instruction: |
Store at-20°C on receipt and minimise freeze-thaw cycles. |
Gene Symbol: |
NET1 |
Gene ID: |
10276 |
Uniprot ID: |
ARHG8_HUMAN |
Immunogen Region: |
C-Term |
Accession Number: |
NP_001040625.1; NP_005854.2 |
Specificity: |
This antibody is expected to recognize both reported isoforms (NP_001040625.1 and NP_005854.2). |
Immunogen Sequence: |
DKALSGGKRKETLV |
Function | Acts as guanine nucleotide exchange factor (GEF) for RhoA GTPase. May be involved in activation of the SAPK/JNK pathway Stimulates genotoxic stress-induced RHOB activity in breast cancer cells leading to their cell death. |
Protein Name | Neuroepithelial Cell-Transforming Gene 1 ProteinProto-Oncogene P65 Net1Rho Guanine Nucleotide Exchange Factor 8 |
Database Links | Reactome: R-HSA-193648Reactome: R-HSA-416482Reactome: R-HSA-8980692Reactome: R-HSA-9013026 |
Cellular Localisation | CytoplasmNucleus |
Alternative Antibody Names | Anti-Neuroepithelial Cell-Transforming Gene 1 Protein antibodyAnti-Proto-Oncogene P65 Net1 antibodyAnti-Rho Guanine Nucleotide Exchange Factor 8 antibodyAnti-NET1 antibodyAnti-ARHGEF8 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance